{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:07:36Z","timestamp":1781280456646,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.medj.2026.101144","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:03:17Z","timestamp":1781276597000},"page":"101144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic retinal disease: Five trials to watch"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3203-2802","authenticated-orcid":false,"given":"Hannah","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir A.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad M.","family":"Khanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2026.101144_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41572-025-00646-x","article-title":"Diabetic retinal disease","volume":"11","author":"Sivaprasad","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.medj.2026.101144_bib2","article-title":"Oculis announces positive top line results from Diamond Stage 1 phase 3 trial in diabetic macular edema with OCS-01 eye drops","year":"2023","journal-title":"Oculis"},{"key":"10.1016\/j.medj.2026.101144_bib3","article-title":"Oculis completes enrollment in both diamond phase 3 trials of OCS-01 in diabetic macular edema","year":"2026","journal-title":"Oculis"},{"key":"10.1016\/j.medj.2026.101144_bib4","article-title":"EyePoint announces first patients dosed in both global phase 3 clinical trials of DURAVYU for the treatment of diabetic macular edema","year":"2026","journal-title":"EyePoint, Inc."},{"key":"10.1016\/j.medj.2026.101144_bib5","unstructured":"Ocular Therapeutix randomizes first patient in helios-3 | ophthalmology times - clinical insights for Eye Specialists."},{"key":"10.1016\/j.medj.2026.101144_bib6","article-title":"REGENXBIO presents positive one year data from Phase II Altitude trial of ABBV-RGX-314 for treatment of diabetic retinopathy using suprachoroidal delivery","year":"2023","journal-title":"Regenxbio Inc."},{"key":"10.1016\/j.medj.2026.101144_bib7","series-title":"4D Molecular Therapeutics","year":"2026"},{"key":"10.1016\/j.medj.2026.101144_bib8","unstructured":"4DMT announces positive long-term data from phase 1\/2 prism clinical trial in wet AMD supporting 4D-150\u2019s potential as a backbone therapy with consistent and durable benefit over multiple years. 4D Molecular Therapeutics. 2025. https:\/\/ir.4dmoleculartherapeutics.com\/news-releases\/news-release-details\/4dmt-announces-positive-long-term-data-phase-12-prism-clinical."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026001479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026001479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:44:31Z","timestamp":1781279071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634026001479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666634026001479"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2026.101144","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic retinal disease: Five trials to watch","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2026.101144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101144"}}